| Hims & Hers | Ro (Ro Body Program) | |
|---|---|---|
| Membership | Required: $39 first month, then auto-renews at $149 a month | $39 to start (refunded if not eligible), then $74 to $149 a month by plan; $74 a month when prepaid annually |
| Medication billing | Separate: "Price includes medication only" | Separate, at manufacturer self-pay prices |
| Wegovy pill | From $149 a month | $149 / $199 / $299 by dose |
| Wegovy pen | From $199 a month | $199 (0.25 and 0.5 mg); $349 (1 to 2.4 mg); $399 (7.2 mg) |
| Zepbound | From $299 a month (vial and KwikPen); pens $1,899 a month | KwikPen $299 (2.5 mg), $399 (5 mg), $449 (7.5 to 15 mg with Lilly's refill terms) |
| Other brands listed | Ozempic pill and Foundayo pill from $149; Ozempic from $199; Mounjaro pens $1,899 a month | None beyond Wegovy and Zepbound in our read |
| Compounded GLP-1s | Not advertised; "limited scale" if a provider finds it clinically necessary (March 9, 2026) | Not offered |
How do Hims and Ro charge for GLP-1 treatment?
Both use the same basic structure: you pay a monthly membership for the clinical service, and you pay for the medication on top. Neither price on its own is the full cost.
The membership amounts overlap. Hims printed $39 for the first month, then $149 a month on auto-renewal. Ro printed $39 to start, refunded if you turn out not to be eligible, then $74 to $149 a month depending on the plan, with $74 a month as the prepaid annual rate.
Medication prices track the manufacturers' self-pay programs closely. Ro's listed Wegovy and Zepbound prices closely follow the ladders NovoCare and Lilly publish. Hims printed "from" prices, which give the entry point but not the price at higher doses.
Which brand medications does each one offer?
Hims listed a wider range in our read. Ro concentrated on Wegovy and Zepbound.
- Hims & Hers: Wegovy pill, Ozempic pill and Foundayo pill from $149 a month; Wegovy pen and Ozempic from $199; Zepbound vial and KwikPen from $299; Mounjaro and Zepbound pens at $1,899 a month.
- Ro: Wegovy pill at $149, $199 or $299 by dose; Wegovy pen from $199 to $399, including the 7.2 mg dose; Zepbound KwikPen at $299, $399 or $449.
Hims' listing of Ozempic is worth reading carefully: Ozempic's FDA label covers type 2 diabetes, not weight management. For label details see the Wegovy and Zepbound pages.
What would 12 months cost at each?
The arithmetic below uses only the prices each company printed on September 17, 2026. It is not a quote, and dose changes, plan choices and price updates would change it.
| Cost line | Hims & Hers | Ro, prepaid annual | Ro, top monthly tier |
|---|---|---|---|
| Membership | $39 + 11 × $149 = $1,678 | 12 × $74 = $888 | $39 + 11 × $149 = $1,678 |
| Medication | 12 × $149 = $1,788 (a "from" price) | 12 × $149 = $1,788 | 12 × $149 = $1,788 |
| Total | $3,466 | $2,676 | $3,466 |
Two caveats. First, Ro's page did not say whether the $39 start fee is added to a prepaid annual plan; if it is, that column rises to $2,715. Second, almost nobody stays at 1.5 mg for a year, since the label escalates the pill to 25 mg from day 91. Using Ro's printed ladder, one month each at 1.5 mg, 4 mg and 9 mg and nine months at 25 mg would cost $149 + $199 + $299 + 9 × $299 = $3,338 in medication. Hims printed no per-dose prices, so we cannot run the same calculation for it.
Does Hims still offer compounded GLP-1s?
Only on a limited basis, by its own account. In a March 9, 2026 statement, Hims said it would no longer advertise compounded GLP-1s, said existing patients would have the opportunity to transition to FDA-approved medicines, and said compounded semaglutide would remain available on a limited scale when a provider decides it is clinically necessary. It repeated the "limited scale" wording in its August 2026 quarterly report. Ro's program, in our read, offered no compounded GLP-1.
What is the FTC lawsuit against Hims about?
On July 29, 2026, the FTC (court docket), the state of Utah and Los Angeles County sued Hims & Hers in federal court in San Francisco (No. 3:26-cv-07871-VC); five more states joined on November 10, 2026. The complaint alleges that most consumers were charged and enrolled without a provider consultation, that monthly refills were not clearly disclosed, that online cancellation was hard to find, and that health data was shared with advertising platforms.
These are allegations, not findings. Hims called the claims baseless and moved to dismiss on October 22, 2026; its quarterly report filed November 9, 2026 says the hearing is set for January 14, 2027. No ruling or settlement had been filed, and the case does not claim Hims' medications were unsafe. The full timeline is in our Hims FTC lawsuit explainer.
What should you check before choosing either?
Because both sites blocked our October re-reads, start with the current pages: hims.com/weight-loss and ro.co pricing.
- The membership price after the first month, and whether it auto-renews.
- The medication price at the dose you will reach, not the starting dose.
- Whether you see a clinician before you are charged, and how refills are confirmed.
- How to cancel online, and what happens to a shipment already in progress.
- Whether your insurance would cover the drug outside either program.
Our provider reviews of Hims & Hers and Ro hold the full notes from each read.
Frequently asked questions
Is Ro cheaper than Hims for GLP-1s?
On the September 17, 2026 pages, it depends on the plan. Both printed $39 for the first month and listed the Wegovy pill from $149. Ro's prepaid annual membership was $74 a month versus Hims' $149 a month after month one, which makes Ro's total lower in that case. Ro's top monthly tier matched Hims at $149.
Does the Hims membership include the medication?
No. Hims' weight-loss page, read September 17, 2026, said its brand medication prices include medication only, and listed a required membership separately: $39 for the first month, then $149 a month on auto-renewal. Ro also bills medication separately from its membership. In both cases, add the two together to get a monthly cost.
Which GLP-1 brands does Ro offer?
In our September 17, 2026 read, Ro listed the Wegovy pill ($149, $199 or $299 by dose), the Wegovy pen ($199 at 0.25 and 0.5 mg, $349 at 1 to 2.4 mg, $399 at 7.2 mg) and the Zepbound KwikPen ($299, $399 or $449 under Lilly's refill terms), billed separately from membership. Ro did not offer compounded GLP-1s.
Is the FTC case a reason to avoid Hims?
That is your call. The case, filed July 29, 2026 by the FTC, Utah and Los Angeles County and joined by five more states on November 10, alleges billing, refill, cancellation and data-sharing problems; Hims denies them and moved to dismiss on October 22, 2026, with a hearing set for January 14, 2027, per its November 9, 2026 quarterly report. No court has ruled, and the case does not allege that Hims' medications were unsafe.
Why are these prices from September 2026?
Both hims.com and ro.co returned errors to our reader on October 15, 2026, so we carried the prices from our last successful read on September 17, 2026, rather than guess. Brand GLP-1 prices and offers can change quickly, so confirm each company's current membership and medication prices on its own site before you sign up.
Sources
- Hims & Hers: weight loss page — read 2026-09-17; re-read returned 403 on 2026-10-15
- Ro: weight loss pricing — read 2026-09-17; re-read returned 403 on 2026-10-15
- Hims & Hers: Announces Strategic Shift for U.S. Weight Loss Business (8-K press release) — March 9, 2026; 'limited scale' wording repeated in Q2 2026 10-Q filed August 10, 2026
- Court docket, FTC v. Hims & Hers (CourtListener) — press release July 29, 2026
- CourtListener docket: FTC v. Hims & Hers Health, Inc., No. 3:26-cv-07871-VC (N.D. Cal.) — motion to dismiss filed 2026-10-22; hearing 2027-01-07; docket read 2026-11-08
- Hims & Hers: Responds to FTC Lawsuit — statement July 29, 2026